ATEM Capital

ATEM Capital is a New York-based venture capital firm founded in 2014 that specializes in early, late-stage, and growth capital investments within the life sciences sector . The firm primarily targets the biotechnology and pharmaceuticals fields, allocating 70% of its investments to these areas, which includes a focus on early-stage and late-stage assets. Additionally, it invests in de-risked medical devices and diagnostics, accounting for the remaining 30% of its portfolio . ATEM Capital is particularly interested in life-saving and life-changing technologies, including those related to oncology, cardiovascular health, anti-infectives, CNS/pain management, and women's health .